MPX Bioceutical Corporation (CSE: MPX) (OTCQX: MPXEF) - Investor Dashboard
| ➔ MPX Bioceutical Corp | |||||
|---|---|---|---|---|---|
| CSE Symbol: | MPX | ||||
| OTCQX Ticker: | MPXEF | ||||
| Sector: | Healthcare |
| Industry: | Legal Cannabis |
| Country: | Canada |
| Employees: | 83 |
| Established: | 1974 |
| CEO: | Scott Boyes |
MPX Bioceutical Corporation – Recent Financing
- 05/25/18 – Size: US$49.5mm – Security: Convertible note at C$0.74, with 42.6 million warrants at C$1.01 – Price: US$812.06 per US$1000
- 12/22/17 – Size: C$26.5mm – Security: 56.33mm units via private placement, with 28.16mm warrants at C$0.64 – Price: C$0.47
- 03/31/17-05/03/17 – Size: C$14.93mm – Security: 29.85mm common shares via private placement – Price: C$0.50
- 01/19/17 – Size: C$35.66mm – Security: 177.41mm common shares via private placement – Price: C$0.20
Visit MPX Bioceutical Corporation,
at www.mpxbioceutical.com.
New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. MPX Bioceutical Corporation is a client of NCV Media, LLC. Read our full disclaimer.